Office-Based Opioid Treatment (OBOT) with buprenorphine has been available since 2000;
however, many barriers to OBOT within primary care exist, and only 3.6% of family medicine …

Many physicians avoid involving themselves in the treatment of addictive disorders because
of poor education about addiction, limited opportunities to coordinate a patient's transition to …

The current opioid epidemic is a public health emergency recognized at the highest levels of
the US government. 1 Despite this attention, the rural overdose death rate continues to …

Background: Substance use disorders, including opioid use disorder (OUD), are understood
as chronic diseases with a relapsing and remitting course and no known cure. Medications …

After leading the world in opioid consumption and manufacturing, the USA is beginning to
gain ground in responding to its opioid epidemic, in part by broadening efforts to provide …

Opioids were involved in 42,249 deaths in the United States in 2016, and opioid overdoses
have quintupled since 1999. 1 Among the causes behind these statistics is increased opiate …

Background Opioid addiction is a chronic disease treatable in primary care settings with
buprenorphine hydrochloride, but this treatment remains underused. We describe a …

Drug Control Policy and the US Department of Health and Human Services to prioritize
increasing access to medication-assisted treatment. 1, 2 The Drug Addiction Treatment Act …

Background Office-based opioid treatment (OBOT) is an evidence-based treatment model
for opioid use disorder (OUD) offered by both addiction and general primary care providers …

Opioid use disorder (OUD) has become common in many regions of Canada, particularly in
rural northwest Ontario. 1, 2 In the past, addicted patients had to access methadone …